ResMed | RMD - Gross Profit On Sales

Stock Price
255.09
Daily Change
-1.97 -0.77%
Monthly
-1.02%
Yearly
9.24%
Q1 Forecast
251.09

ResMed reported $878.72M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Ansell USD 326.2M 27.6M Jun/2024
Artivion USD 61.01M 2.32M Sep/2024
AtriCure USD 105.34M 4M Dec/2025
Baxter International USD 577M 373M Dec/2025
Cochlear AUD 426.8M 454.9M Jun/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
CSL USD 1.75B 2.53B Jun/2025
Dexcom USD 792.7M 61.3M Dec/2025
Edwards Lifesciences USD 1.23B 18.7M Dec/2025
Fisher Paykel Healthcare NZD 685.7M 3.5M Dec/2025
Globus Medical USD 535.95M 49.28M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Hologic USD 586.4M 2.9M Dec/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Inogen USD 41.34M 1.39M Sep/2024
Insulet USD 568.6M 58.5M Dec/2025
Integra LifeSciences USD 217.1M 10.11M Dec/2025
Intuitive Surgical USD 1.9B 241.9M Dec/2025
Masimo USD 230.6M 2.7M Sep/2025
Medtronic USD 5.41B 27M Dec/2025
Philips EUR 2.29B 377M Dec/2025
Ramsay Health Care AUD 549.95M 5.77B Jun/2025
ResMed USD 878.72M 57.9M Dec/2025
Sigma Healthcare AUD 160.13M 10.55M Jul/2024
Sonic Healthcare AUD 3.92B 3.14B Dec/2024
Steris USD 655.5M 9.6M Dec/2025
Teleflex USD 307.45M 144.2M Dec/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025